首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2050775

生物製藥市場：依產品、藥物分類、給藥途徑、購買方式、通路及地區分類

Biologics Market, By Product, By Drug Classification, By Route of Administration, By Mode of Purchase, By Distribution Channel,By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2026年生物製藥市場規模為6.399億美元，到2033年將達到13.118億美元。預計2026年至2033年，該市場將以10.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	6.399億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	10.80%	2033年市場規模預測：	13.118億美元

生物製藥是指生物來源的藥物，用於預防、治療和治癒人類疾病。這些藥物包括疫苗、血液製品、過敏原製劑、體細胞、基因療法、組織和重組治療性蛋白質。慢性病在全球日益普遍，加上老年人口不斷成長且易患各種疾病，可能會推動對生物製藥的需求。生物技術領域的快速創新和進步使得開發具有更高安全性、有效性和作用特異性的新型生物製藥成為可能。這拓寬了多種危及生命的疾病的治療選擇，包括癌症、風濕性疾病和自體免疫疾病。生物製藥監管核准和商業化的不斷推進有望推動市場成長。

市場動態

全球生物製藥市場的成長主要受以下因素驅動：糖尿病、癌症和心血管疾病等慢性疾病在全球範圍內的日益流行，以及醫療保健領域在生物製藥研發方面投入的不斷增加。此外，對蛋白質類藥物的需求不斷成長、先進生物製藥的快速核准以及大量新型生物製藥候選藥物的湧現，也是推動市場成長的重要因素。生物加工和品質分析技術的持續進步，使得高產量生產平台得以開發，從而能夠以經濟高效的方式進行商業規模的生物製藥生產。然而，生物製藥設施建設所需的大量資本投入、嚴格的監管標準以及生物分子的複雜性等因素，都為生物相似藥的開發帶來了挑戰。亞太和拉丁美洲等新興市場為相關人員提供了開拓新區域市場、抵銷上述限制因素影響的機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數創建了全球生物製藥市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品等級改進、市場擴張和行銷策略做出明智的決策。
這份全球生物製劑市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種用於分析全球生物製藥市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Hoffmann-La Roche Ltd.
AbbVie Inc.
Amgen Inc.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Pfizer Inc.
Sanofi SA
Gilead Sciences, Inc.
Novartis AG
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Biogen Inc.
Eli Lilly and Company
Celltrion Healthcare Co., Ltd.

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI2663

Biologics Market is estimated to be valued at USD 639.9 Mn in 2026 and is expected to reach USD 1,311.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 639.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.80%	2033 Value Projection:	USD 1,311.8 Mn

Biologics refers to medicines created from living organisms that are used to prevent, treat, and cure human diseases. These include vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Increasing prevalence of chronic diseases worldwide coupled with rising elderly population prone to various illnesses can boost demand for biologics. Rapid innovations and advancements in biotechnology have enabled development of novel biologic agents with improved safety, efficacy and specificity of action. This has expanded treatment options for several life threatening conditions such as cancer, rheumatic disorders, and autoimmune diseases. Growing regulatory approvals and commercialization of biologics can drive the market growth.

Market Dynamics

Global biologics market growth is driven by growing prevalence of chronic diseases worldwide such as diabetes, cancer, cardiovascular diseases along with rising healthcare expenditure on biopharmaceutical R&D. Increasing demand for protein based drugs, rapid approvals of advanced biologics and strong pipeline of novel biologic candidates can also drive the market growth. Constant technological advancements in bioprocessing and quality analytics enables development of high yield production platforms conducive for cost effective manufacturing of biologics at commercial scale. However, factors such as high capital investment needs for setting up bio manufacturing facilities, stringent regulatory norms, and complexity of biological molecules poses challenges in biosimilar development. Emerging markets across developing regions such as Asia Pacific and Latin America offer lucrative opportunities for stakeholders to tap into new geographic territories and offset restraint impact.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global biologics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include F. Hoffmann La Roche Ltd., AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Novartis AG, Bristol Myers Squibb Company, Regeneron Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Eli Lilly and Company, and Celltrion Healthcare Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics.
Global biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global biologics market.

Market Segmentation

By Product Insights (Revenue, USD Mn, 2021 - 2033)
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cellular-based Biologics
Gene-based Biologics
Others
By Drug Classification Insights (Revenue, USD Mn, 2021 - 2033)
Branded Drugs
Generic Drugs
By Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
Oral
Parenteral
Other Routes
By Mode of Purchase Insights (Revenue, USD Mn, 2021 - 2033)
Prescription-Based Drugs
Over-The-Counter Drugs
By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
F. Hoffmann-La Roche Ltd.
AbbVie Inc.
Amgen Inc.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Pfizer Inc.
Sanofi S.A.
Gilead Sciences, Inc.
Novartis AG
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Biogen Inc.
Eli Lilly and Company
Celltrion Healthcare Co., Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biologics Market, By Product
- Global Biologics Market, By Drug Classification
- Global Biologics Market, By Route of Administration
- Global Biologics Market, By Mode of Purchase
- Global Biologics Market, By Distribution Channel
- Global Biologics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Biologics Market, By Product, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Recombinant Hormones/Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Cellular-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Gene-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Biologics Market, By Drug Classification, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Biologics Market, By Route of Administration, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Other Routes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Biologics Market, By Mode of Purchase, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Prescription-Based Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Over-The-Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Biologics Market, By Distribution Channel, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

9. Global Biologics Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Celltrion Healthcare Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies